Antisense therapeutics in chronic myeloid leukaemia: the promise, the progress and the problems
Author:
Publisher
Springer Science and Business Media LLC
Subject
Oncology,Cancer Research,Hematology
Link
http://www.nature.com/articles/2401677.pdf
Reference133 articles.
1. Nienhuis AW . Genetic mechanisms in neoplasia Blood 1984 64: 949–950
2. Anderson WF . Human gene therapy Nature 1998 392: 25–30
3. Verma IM, Somia N . Gene therapy–promises, problems and prospects Nature 1997 389: 239–242
4. Gewirtz AM, Sokol DL, Ratajczak MZ . Nucleic acid therapeutics: state of the art and future prospects Blood 1998 92: 712–736
5. Kiehntopf M, Esquivel EL, Brach MA, Herrmann F . Clinical application of ribozymes Lancet 1995 345: 1027–1031
Cited by 35 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. ASP210: a potent oligonucleotide-based inhibitor effective against TKI-resistant CML cells;American Journal of Physiology-Cell Physiology;2024-07-01
2. Targeting multiple signaling pathways: the new approach to acute myeloid leukemia therapy;Signal Transduction and Targeted Therapy;2020-12
3. Chronic myelogenous leukemia on target;Cancer Medicine;2018-06-14
4. The Size of the Internal Loop in DNA Hairpins Influences Their Targeting with Partially Complementary Strands;The Journal of Physical Chemistry B;2014-12-19
5. Attacking c-Myc: Targeted and Combined Therapies for Cancer;Current Pharmaceutical Design;2014-10-22
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3